NARA Discovery
Article Details
← Back to Search Results
Journal Article

Is atezolizumab plus bevacizumab as first-line therapy for unresectable hepatocellular carcinoma superior to lenvatinib? a systematic review and meta‑analysis

Gang Zhu; Longfei Zeng; Liu Yang; Xin Zhang; Jinquan Tang; Yong Pan; Bo Li; Mengchen Chen; Tao Wu
European Journal of Clinical Pharmacology · Vol. 80, Issue 10 · pp. 1425-1434 · 2024

Abstract

Abstract is unavailable.

Bibliographic Information

JournalEuropean Journal of Clinical Pharmacology
PublisherSpringer
Publication Date2024-10-01
Publication Year2024
Volume80
Issue10
Pages1425-1434
Document TypeJournal Article
Print ISSN0031-6970
eISSN1432-1041
DOI10.1007/s00228-024-03718-1

Access Information

NARA Access Coverage1968-01-01~Current
Journal Homepagehttps://www.springer.com/journal/228
Publisher PageOpen Publisher Page
Full-text access depends on NARA's subscribed coverage and institutional access.